LCI 1318
Pill imprint LCI 1318 has been identified as Terbutaline sulfate 2.5 mg.
Terbutaline is used in the treatment of premature labor; asthma, maintenance; asthma, acute and belongs to the drug classes adrenergic bronchodilators, tocolytic agents. There is no proven risk in humans during pregnancy.
Terbutaline 2.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Terbutaline sulfate Images
- Imprint:
-
LCI 1318
- Strength:
- 2.5 mg
- Color:
- White
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
lactose anhydrous
magnesium stearate
povidone
pregelatinized corn starch
- Drug Class:
- Adrenergic bronchodilators
Tocolytic agents - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Lannett Company, Inc.
- National Drug Code (NDC):
- 00527-1318
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0256 | Amerisource Health Services |
Note: Inactive ingredients may vary.
Advertisement
More Terbutaline Sulfate resources
- Terbutaline (Wolters Kluwer)
- Terbutaline Tablets (Wolters Kluwer)
- terbutaline (Cerner Multum)
- terbutaline inhalation (Cerner Multum)
- terbutaline (Micromedex) - Includes Dosage Information
- terbutaline Subcutaneous (Micromedex) - Includes Dosage Information
- Terbutaline Sulfate (AHFS DI)
- Terbutaline (FDA)
- Terbutaline Tablets (FDA)
- Terbutaline Sulfate (Wolters Kluwer)
Search Again
